Le Lézard
Classified in: Health
Subjects: PDT, TRI


TORONTO, Jan. 28, 2022 /CNW/ - Lilly Canada is pleased to announce that as of January 31st, 2022, Baqsimi (glucagon nasal powder) is now covered under the Ontario Drug Benefit (ODB) Formulary, as a Limited Use (LU) benefit. 

Baqsimi is indicated for the treatment of severe hypoglycemic reactions in people with insulin-treated diabetes mellitus 4 years old and above when impaired consciousness precludes oral carbohydrates.

"Baqsimi has the potential to provide patients and those who are close to them with the confidence to manage unexpected severe blood sugar lows with an easy-to-use nasal formulation and we're so pleased that Ontario has granted public access to this important rescue medication," says Rhonda Pacheco, General Manager, Lilly Canada.

Baqsimi received approval from Health Canada in the fall of 2019 and to date, all Federal Health Benefit programs now include Baqsimi on their formularies.

About Baqsimi 
Baqsimi is a portable, ready-to-use form of glucagon which requires no reconstitution or priming. It is administered in a single fixed dose of 3 mg which is sprayed in the nose, where it is absorbed. Baqsimi does not need to be refrigerated and can be stored at temperatures up to 30°C/86°F in its shrink-wrapped tube. Baqsimi is indicated for the treatment of severe hypoglycemic reactions in people with insulin-treated diabetes mellitus 4 years old and above when impaired consciousness precludes oral carbohydrates. The formulation was discovered in Canada.

About Lilly Canada
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by Colonel Eli Lilly, who was committed to creating high quality medicines that meet people's needs, and today we remain true to that mission in all our work. Lilly employees work to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to our communities through philanthropy and volunteerism.

Eli Lilly Canada was established in 1938, the result of a research collaboration with scientists at the University of Toronto which eventually produced the world's first commercially available insulin. Our work focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. To learn more about Lilly Canada, please visit us at www.lilly.ca.

For our perspective on issues in healthcare and innovation, follow us on twitter @LillyPadCA. 

SOURCE Eli Lilly Canada Inc.

These press releases may also interest you

at 21:19
The Public Health Agency of Canada (PHAC) is working with the United States Centers for Disease Control and Prevention, and public health authorities in the province of Quebec to investigate potential exposure and contacts of a case of monkeypox...

at 20:30
The Physiotherapy Market size is expected to grow by USD 6.00 billion from 2021 to 2026, progressing at a CAGR of 5.44% during the forecast period, according to Technavio. The report offers an up-to-date analysis and to know the exact growth variance...

at 20:05
CANbridge Pharmaceuticals Inc. (HKEX:1228), a China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, today announced that it will...

at 19:00
Vanda Pharmaceuticals Inc. (Vanda) today announced participation at Digestive Disease Week (DDW) 2022, to be held in San Diego, CA and online from May 21-24, 2022. The following will be presented: May 21, 2022 Presentation Title: "THE ROLE OF M1 TO...

at 18:56
SEIU Healthcare, a union that represents 60,000 healthcare workers in the province of Ontario, has retained Ruby Shiller Enenajor DiGiuseppe (RSED) LLP to explore all legal options to defend union members who sustained injuries at Monday's leaders'...

at 18:38
Biogénesis Bagó, a global animal health biotechnology company, hosted a seminar in Jordan where it presented to government authorities, international organizations, producers and customers from 14 countries in the Middle East and North Africa, its...

News published on 28 january 2022 at 11:59 and distributed by: